Modification of GABA-mediated inhibition by various injectable anesthetics

Timothy E Albertson, W. F. Walby, R. M. Joy

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Increasing doses of the injectable anesthetics etomidate, Saffan, thiopental, ketamine, and xylazine and the vehicles saline and propylene glycol were administered to urethane-anesthetized rats. Their effects in vivo on perforant pathway-evoked field excitatory postsynaptic potentials and population spikes in the hippocampal dentate gyrus were determined. The primary purpose was to ascertain whether these compounds affect hippocampal excitability in a manner consistent with their proposed mechanisms of action. Compared with their respective vehicles, thiopental, etomidate, and xylazine reduced the amplitude of population spikes to single perforant pathway stimulation by 20-30% at the highest doses tested. Xylazine also increased the latency to onset of the population spike. No other effects were observed. Using paired pulse paradigms, it was determined that etomidate produced a dramatic, prolonged reduction in granule cell excitability at interpulse intervals of 10-100 ms. The magnitude of the effect was dose related and was reversible with the discontinuance of administration of the drug. Similar changes occurred with Saffan (althesin) and thiopental. Ketamine produced a small but significant depression in granule cell excitability during intervals of 10-200 ms. Xylazine had no effect. These data corroborate the importance of a prolongation of γ-aminobutyric acid A-mediated inhibition to the mechanism of actions of etomidate, thiopental, and Saffan at relevant exposure concentrations in vivo.

Original languageEnglish (US)
Pages (from-to)488-499
Number of pages12
JournalAnesthesiology
Volume77
Issue number3
StatePublished - 1992

Fingerprint

Alfaxalone Alfadolone Mixture
Etomidate
Xylazine
Thiopental
gamma-Aminobutyric Acid
Anesthetics
Perforant Pathway
Injections
Ketamine
Population
Aminobutyrates
Parahippocampal Gyrus
Propylene Glycol
Excitatory Postsynaptic Potentials
Urethane
Dentate Gyrus
Pharmaceutical Preparations

Keywords

  • Anesthetics, intraperitoneal: Saffan (althesin); etomidate; ketamine; thiopental; xylazine
  • Brain, hippocampus: evoked potentials; perforant pathway

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Modification of GABA-mediated inhibition by various injectable anesthetics. / Albertson, Timothy E; Walby, W. F.; Joy, R. M.

In: Anesthesiology, Vol. 77, No. 3, 1992, p. 488-499.

Research output: Contribution to journalArticle

Albertson, Timothy E ; Walby, W. F. ; Joy, R. M. / Modification of GABA-mediated inhibition by various injectable anesthetics. In: Anesthesiology. 1992 ; Vol. 77, No. 3. pp. 488-499.
@article{a2ba3a1fdb634c1fb2a88db1eddc33d5,
title = "Modification of GABA-mediated inhibition by various injectable anesthetics",
abstract = "Increasing doses of the injectable anesthetics etomidate, Saffan, thiopental, ketamine, and xylazine and the vehicles saline and propylene glycol were administered to urethane-anesthetized rats. Their effects in vivo on perforant pathway-evoked field excitatory postsynaptic potentials and population spikes in the hippocampal dentate gyrus were determined. The primary purpose was to ascertain whether these compounds affect hippocampal excitability in a manner consistent with their proposed mechanisms of action. Compared with their respective vehicles, thiopental, etomidate, and xylazine reduced the amplitude of population spikes to single perforant pathway stimulation by 20-30{\%} at the highest doses tested. Xylazine also increased the latency to onset of the population spike. No other effects were observed. Using paired pulse paradigms, it was determined that etomidate produced a dramatic, prolonged reduction in granule cell excitability at interpulse intervals of 10-100 ms. The magnitude of the effect was dose related and was reversible with the discontinuance of administration of the drug. Similar changes occurred with Saffan (althesin) and thiopental. Ketamine produced a small but significant depression in granule cell excitability during intervals of 10-200 ms. Xylazine had no effect. These data corroborate the importance of a prolongation of γ-aminobutyric acid A-mediated inhibition to the mechanism of actions of etomidate, thiopental, and Saffan at relevant exposure concentrations in vivo.",
keywords = "Anesthetics, intraperitoneal: Saffan (althesin); etomidate; ketamine; thiopental; xylazine, Brain, hippocampus: evoked potentials; perforant pathway",
author = "Albertson, {Timothy E} and Walby, {W. F.} and Joy, {R. M.}",
year = "1992",
language = "English (US)",
volume = "77",
pages = "488--499",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Modification of GABA-mediated inhibition by various injectable anesthetics

AU - Albertson, Timothy E

AU - Walby, W. F.

AU - Joy, R. M.

PY - 1992

Y1 - 1992

N2 - Increasing doses of the injectable anesthetics etomidate, Saffan, thiopental, ketamine, and xylazine and the vehicles saline and propylene glycol were administered to urethane-anesthetized rats. Their effects in vivo on perforant pathway-evoked field excitatory postsynaptic potentials and population spikes in the hippocampal dentate gyrus were determined. The primary purpose was to ascertain whether these compounds affect hippocampal excitability in a manner consistent with their proposed mechanisms of action. Compared with their respective vehicles, thiopental, etomidate, and xylazine reduced the amplitude of population spikes to single perforant pathway stimulation by 20-30% at the highest doses tested. Xylazine also increased the latency to onset of the population spike. No other effects were observed. Using paired pulse paradigms, it was determined that etomidate produced a dramatic, prolonged reduction in granule cell excitability at interpulse intervals of 10-100 ms. The magnitude of the effect was dose related and was reversible with the discontinuance of administration of the drug. Similar changes occurred with Saffan (althesin) and thiopental. Ketamine produced a small but significant depression in granule cell excitability during intervals of 10-200 ms. Xylazine had no effect. These data corroborate the importance of a prolongation of γ-aminobutyric acid A-mediated inhibition to the mechanism of actions of etomidate, thiopental, and Saffan at relevant exposure concentrations in vivo.

AB - Increasing doses of the injectable anesthetics etomidate, Saffan, thiopental, ketamine, and xylazine and the vehicles saline and propylene glycol were administered to urethane-anesthetized rats. Their effects in vivo on perforant pathway-evoked field excitatory postsynaptic potentials and population spikes in the hippocampal dentate gyrus were determined. The primary purpose was to ascertain whether these compounds affect hippocampal excitability in a manner consistent with their proposed mechanisms of action. Compared with their respective vehicles, thiopental, etomidate, and xylazine reduced the amplitude of population spikes to single perforant pathway stimulation by 20-30% at the highest doses tested. Xylazine also increased the latency to onset of the population spike. No other effects were observed. Using paired pulse paradigms, it was determined that etomidate produced a dramatic, prolonged reduction in granule cell excitability at interpulse intervals of 10-100 ms. The magnitude of the effect was dose related and was reversible with the discontinuance of administration of the drug. Similar changes occurred with Saffan (althesin) and thiopental. Ketamine produced a small but significant depression in granule cell excitability during intervals of 10-200 ms. Xylazine had no effect. These data corroborate the importance of a prolongation of γ-aminobutyric acid A-mediated inhibition to the mechanism of actions of etomidate, thiopental, and Saffan at relevant exposure concentrations in vivo.

KW - Anesthetics, intraperitoneal: Saffan (althesin); etomidate; ketamine; thiopental; xylazine

KW - Brain, hippocampus: evoked potentials; perforant pathway

UR - http://www.scopus.com/inward/record.url?scp=0026795379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026795379&partnerID=8YFLogxK

M3 - Article

C2 - 1519787

AN - SCOPUS:0026795379

VL - 77

SP - 488

EP - 499

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 3

ER -